| MeSH term | MeSH ID | Detail |
|---|---|---|
| Candidemia | D058387 | 2 associated lipids |
| Aspergillosis | D001228 | 5 associated lipids |
| Blastomycosis | D001759 | 5 associated lipids |
| Xerostomia | D014987 | 6 associated lipids |
| Vaginitis | D014627 | 6 associated lipids |
| Gonorrhea | D006069 | 7 associated lipids |
| Candidiasis, Vulvovaginal | D002181 | 8 associated lipids |
| Otitis Externa | D010032 | 8 associated lipids |
| AIDS-Related Opportunistic Infections | D017088 | 9 associated lipids |
| Urethritis | D014526 | 9 associated lipids |
| Vaginosis, Bacterial | D016585 | 10 associated lipids |
| Influenza, Human | D007251 | 11 associated lipids |
| Candidiasis, Oral | D002180 | 11 associated lipids |
| Pregnancy Complications, Infectious | D011251 | 11 associated lipids |
| HIV Seropositivity | D006679 | 15 associated lipids |
| Dermatomycoses | D003881 | 17 associated lipids |
| Mycoses | D009181 | 18 associated lipids |
| Leishmaniasis | D007896 | 19 associated lipids |
| Anemia, Sickle Cell | D000755 | 34 associated lipids |
| Burns | D002056 | 34 associated lipids |
Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Fernández-Campos F et al. | Evaluation of novel nystatin nanoemulsion for skin candidosis infections. | 2013 | Mycoses | pmid:22574899 |
| Godoy JS et al. | Colonization of the oral cavity by yeasts in patients with chronic renal failure undergoing hemodialysis. | 2013 | J. Oral Pathol. Med. | pmid:22978344 |
| Silva S et al. | The effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylic. | 2013 | Med. Mycol. | pmid:22803822 |
| Kim DH et al. | Differential regulation of CC chemokine ligand 2 and CXCL8 by antifungal agent nystatin in macrophages. | 2013 | Biochem. Biophys. Res. Commun. | pmid:23831464 |
| Melkoumov A et al. | Nystatin nanosizing enhances in vitro and in vivo antifungal activity against Candida albicans. | 2013 | J. Antimicrob. Chemother. | pmid:23620465 |
| Kanlaya R et al. | Macropinocytosis is the major mechanism for endocytosis of calcium oxalate crystals into renal tubular cells. | 2013 | Cell Biochem. Biophys. | pmid:23695784 |
| Chen Y et al. | Antifungal mechanism of essential oil from Anethum graveolens seeds against Candida albicans. | 2013 | J. Med. Microbiol. | pmid:23657528 |
| Kumano-Kuramochi M et al. | Lectin-like oxidized LDL receptor-1 is palmitoylated and internalizes ligands via caveolae/raft-dependent endocytosis. | 2013 | Biochem. Biophys. Res. Commun. | pmid:23583401 |
| Austin N et al. | Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants. | 2013 | Cochrane Database Syst Rev | pmid:23543519 |
| MartÃn-Villena MJ et al. | Novel microparticulate systems for the vaginal delivery of nystatin: development and characterization. | 2013 | Carbohydr Polym | pmid:23544502 |
| Pál S et al. | Technological and biopharmaceutical optimization of nystatin release from a multiparticulate based bioadhesive drug delivery system. | 2013 | Eur J Pharm Sci | pmid:23528741 |
| Demirel G et al. | Prophylactic Saccharomyces boulardii versus nystatin for the prevention of fungal colonization and invasive fungal infection in premature infants. | 2013 | Eur. J. Pediatr. | pmid:23703468 |
| Monteiro DR et al. | Antifungal activity of silver nanoparticles in combination with nystatin and chlorhexidine digluconate against Candida albicans and Candida glabrata biofilms. | 2013 | Mycoses | pmid:23773119 |
| El-Wahidi M et al. | [Bio-guided isolation of an antifungal from Haliclona enamela collected from Jorf Lasfar port, Morocco]. | 2013 | J Mycol Med | pmid:23726234 |
| Torres-Alvarez B et al. | Cutaneous congenital candidiasis in a full-term newborn from an asymptomatic mother. | 2013 | Dermatol. Online J. | pmid:24010513 |
| Lin TY et al. | Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction. | 2013 | Cell Rep | pmid:24268777 |
| Chen Z et al. | [The clinical research of nystatin in prevention of invasive fungal infections in patients on mechanical ventilation in intensive care unit]. | 2013 | Zhonghua Wei Zhong Bing Ji Jiu Yi Xue | pmid:24021043 |
| Reis DC et al. | Structural studies and investigation on the activity of imidazole-derived thiosemicarbazones and hydrazones against crop-related fungi. | 2013 | Molecules | pmid:24129274 |
| Maroszyńska M et al. | Antibiotics sensitivity of Candida clinical and food-borne isolates. | 2013 | Acta Biochim. Pol. | pmid:24432323 |
| Milton Rocha Gusmão J and Pereira RP | Treatment protocol for denture stomatitis, prior to anatomical molding. | 2013 | Gerodontology | pmid:22506854 |